Skip to content

Opko Health OPK EPS (Diluted)

EPS (Diluted) at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$2.24+15.5%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$0.52-44.4%
HRO
HarrowHROW
-$0.74-48.0%
Precigen logo
PrecigenPGEN
-$0.02+88.9%
Immunome logo
ImmunomeIMNM
-$0.48+7.7%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$1.84-17.2%

Other financials

Income statement

See full
Revenue$124.2M-17.2%
Gross profit$45.8M+7.4%
Operating income-$51.0M+24.0%
Net income-$54.8M+18.9%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$52.8M-4.2%
Total equity$1.2B-8.2%
Total assets$1.9B-12.8%

Cash flow

See full
Operating cash flow-$19.3M+44.1%
CapEx$1.8M-42.6%
Free cash flow-$21.1M+44.0%

Valuation

See full
Market cap$1.13B-22.4%
P/S1.9×-0.2×

Profitability

See full
Gross margin36%+4.2pp
Operating margin-17.4%-5.6pp
Net margin-36.6%-44.8pp
FCF margin-30%+0.1pp

Returns & leverage

See full
Return on equity-16.9%-21.7pp
Debt / equity0.0×
Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opko Health's EPS (diluted)?
Opko Health (OPK) reported EPS (diluted) of -$0.07 in Q1 2026.
How has Opko Health's EPS (diluted) changed year-over-year?
Opko Health's EPS (diluted) increased by 30.0% year-over-year, from -$0.10 to -$0.07.
What is the long-term trend for Opko Health's EPS (diluted)?
Over 3 years (2021 to 2025), Opko Health's EPS (diluted) has grown at a 81.7% compound annual growth rate (CAGR), from -$0.05 to -$0.30.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.